(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZIRCAIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ZIRCAIX

ST13

US500000079375152

Class

5, 10

Filing

79375152

Registration

7435713

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

07/30/2026

Trademark type

Word

Nice classes

5, 10

Filing date

06/29/2023

Registration date

07/09/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/09/2024

Last transaction

07/30/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

AU

Examiner

NICHOLSON, CIERRIA W

Law office

O40

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Telix Pharmaceuticals Limited

Representatives

Herbert Smith Freehills

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemical preparations for pharmaceutical purposesdiagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imagingdiagnosingmonitoring and treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imagingdiagnosingmonitoring and treatment of cancer

Class 10

Medical apparatusinfusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposesdrug delivery devices sold emptysyringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use

Publications

History of USPTO decisions and trademark events.

19 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/30/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/22/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/01/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/10/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/25/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

12/25/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/08/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

07/09/2024

GPNX

NOTIFICATION PROCESSED BY IB

04/23/2024

PUBO

PUBLISHED FOR OPPOSITION

04/23/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/03/2024

NPUB

NOTICE OF PUBLICATION

04/03/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/18/2024

DOCK

ASSIGNED TO EXAMINER

03/14/2024

MAFR

APPLICATION FILING RECEIPT MAILED

08/15/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/11/2023

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

08/08/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/27/2023

Continuous trademark protection

Get notified about every new filing that threatens ZIRCAIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.